| Source: |
| Type: |
| Cognitive |
| 4075- | FA, | Folic acid, ageing, depression, and dementia |
| - | Review, | AD, | NA |
| 4074- | FA, | VitB12, | Associations between Alzheimer's disease and blood homocysteine, vitamin B12, and folate: a case-control study |
| - | Trial, | AD, | NA |
| 3712- | FA, | Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants |
| - | Review, | AD, | NA |
| 3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
| - | Review, | AD, | NA |
| 3715- | FA, | CUR, | PS, | The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic Mice |
| - | in-vivo, | AD, | NA |
| 4059- | FA, | Dietary B Vitamins and a 10-Year Risk of Dementia in Older Persons |
| - | Study, | AD, | NA |
| 4044- | FA, | Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial |
| - | Trial, | AD, | NA |
| 3782- | FA, | Ferulic acid ameliorates bisphenol A (BPA)-induced Alzheimer’s disease-like pathology through Akt-ERK crosstalk pathway in male rats |
| - | in-vivo, | AD, | NA |
| 6870- | FA, | Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6884- | FA, | Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6867- | FA, | Ang, | Effect of Feru-guard 100M on amyloid-beta deposition in individuals with mild cognitive impairment |
| - | Trial, | AD, | NA |
| 6866- | FA, | Ang, | Effects of Ferulic Acid and Angelica archangelica Extract (Feru-guard ®) on Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Prospective Trial |
| - | Trial, | AD, | NA |
| 6875- | FA, | Ferulic Acid Improves Cognitive Skills Through the Activation of the Heme Oxygenase System in the Rat |
| - | in-vivo, | AD, | NA |
| - | Trial, | AD, | NA |
| 6952- | FA, | Knowledge gaps in understanding the metabolic and clinical effects of excess folates/folic acid: a summary, and perspectives, from an NIH workshop |
| - | Review, | AD, | NA |
| 6951- | FA, | Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI |
| - | Trial, | AD, | NA |
| - | Trial, | AD, | NA |
| 6949- | FA, | VitB12, | A controlled trial of homocysteine lowering and cognitive performance |
| - | Trial, | AD, | NA |
| 6948- | FA, | VitB12, | A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people |
| - | Trial, | AD, | NA |
| 6947- | FA, | Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6956- | FA, | VitB12, | A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients |
| - | Trial, | AD, | NA |
| 6961- | FA, | VitB12, | VitB6, | Silicon, | Alum | B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment |
| - | Trial, | AD, | NA |
| 7829- | FA, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| 2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 6908- | FIS, | Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice |
| - | in-vivo, | AD, | NA |
| 4063- | Flav, | VitB12, | VitB6, | Homocysteine and Dementia: An International Consensus Statement |
| - | Review, | AD, | NA |
| 4060- | Flav, | Vitamin Supplementation and Dementia: A Systematic Review |
| - | Review, | AD, | NA |
| - | Review, | AD, | NA |
| 6926- | Flav, | Dietary (Poly)phenols and Cognitive Decline: A Systematic Review and Meta-Analysis of Observational Studies |
| - | Review, | AD, | NA |
| 6925- | Flav, | Important Flavonoids and Their Role as a Therapeutic Agent |
| - | Review, | Nor, | NA |
| 6876- | Flav, | Flavonoid-rich orange juice is associated with acute improvements in cognitive function in healthy middle-aged males |
| - | Trial, | AD, | NA |
| 6933- | FLS, | AudGS, | Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study |
| - | Trial, | AD, | NA |
| 4107- | FLS, | Ex, | Combined effects of aerobic exercise and 40-Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3×Tg mice |
| - | in-vivo, | AD, | NA |
| 4121- | FLS, | Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer’s Disease Patients |
| - | Trial, | AD, | NA |
| 6981- | Form, | Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
| 4017- | FulvicA, | Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease |
| - | NA, | AD, | NA |
| 4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
| - | Review, | AD, | NA |
| 4020- | FulvicA, | Natural products as a rich source of tau-targeting drugs for Alzheimer’s disease |
| - | in-vitro, | AD, | NA |
| 7069- | GABA, | United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA) |
| - | Review, | Nor, | NA |
| 7078- | GABA, | GABA attenuates amyloid toxicity by downregulating its endocytosis and improves cognitive impairment |
| - | in-vivo, | AD, | NA |
| 7079- | GABA, | GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment |
| - | Review, | AD, | NA |
| 7080- | GABA, | The Effect of Oral GABA on the Nervous System: Potential for Therapeutic Intervention |
| - | Review, | AD, | NA |
| 7081- | GABA, | Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut–Brain Axis |
| - | Review, | AD, | NA |
| 7082- | GABA, | Contributions of Gamma-Aminobutyric Acid (GABA) Produced by Lactic Acid Bacteria on Food Quality and Human Health: Current Applications and Future Prospects |
| - | Review, | AD, | NA |
| 4248- | Gala, | Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement |
| - | Review, | NA, | NA |
| 3723- | GBE, | Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies |
| - | Review, | AD, | NA |
| 7197- | GBE, | Ginkgo biloba for cognitive impairment and dementia |
| - | Review, | AD, | NA |
| 7206- | GBE, | EGb 761, | Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review |
| - | Review, | AD, | NA |
| 7188- | GBE, | Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial |
| - | Trial, | AD, | NA |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:557 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid